Ovarian Carcinoma
155
37
57
51
Key Insights
Highlights
Success Rate
69% trial completion
Published Results
30 trials with published results (19%)
Research Maturity
51 completed trials (33% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
14.8%
23 terminated out of 155 trials
68.9%
-17.7% vs benchmark
6%
9 trials in Phase 3/4
59%
30 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 51 completed trials
Clinical Trials (155)
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
The Vanguard Study: Testing a New Way to Screen for Cancer
A Study of Intra-operative Imaging in Women With Ovarian Cancer
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues